Trial
NCT04871529
Testing the Addition of an Anti-Cancer Immunotherapy Drug, Avelumab, to Gemcitabine and Carboplatin Chemotherapy Prior to Surgery in Muscle Invasive Urinary Tract Cancer vs. Surgery Alone in Patients Who Are Not Able to Receive Cisplatin Therapy (SWOG GAP TRIAL)
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
SWOG Cancer Research Network
Collaborators
National Cancer Institute (NCI)
Condition
Bladder Carcinoma Infiltrating the Muscle of the Bladder Wall
Intervention
Therapeutic Conventional Surgery
Why stopped
inability to accrue sufficient patients
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-30